1 Min Read
Nov 2 (Reuters) - PDL Biopharma Inc
* PDL Biopharma Inc announces third quarter 2017 financial results
* Q3 revenue $62.7 million
* PDL Biopharma Inc - qtrly GAAP diluted EPS of $0.14 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.